nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ABCB1—Liothyronine—hypothyroidism	0.12	0.28	CbGbCtD
Mefloquine—ABCB1—Levothyroxine—hypothyroidism	0.12	0.28	CbGbCtD
Mefloquine—ABCB1—Liotrix—hypothyroidism	0.117	0.273	CbGbCtD
Mefloquine—CYP3A4—Levothyroxine—hypothyroidism	0.0721	0.168	CbGbCtD
Mefloquine—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.0319	0.113	CcSEcCtD
Mefloquine—HBA1—urine—hypothyroidism	0.0296	0.115	CbGeAlD
Mefloquine—CYP19A1—corpus luteum—hypothyroidism	0.0253	0.0983	CbGeAlD
Mefloquine—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0214	0.0833	CbGeAlD
Mefloquine—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.0115	0.0407	CcSEcCtD
Mefloquine—ADORA1—nerve—hypothyroidism	0.00842	0.0327	CbGeAlD
Mefloquine—HBA1—heart—hypothyroidism	0.00758	0.0294	CbGeAlD
Mefloquine—HBA1—cardiovascular system—hypothyroidism	0.00715	0.0278	CbGeAlD
Mefloquine—HBA2—heart—hypothyroidism	0.00696	0.027	CbGeAlD
Mefloquine—HBA2—cardiovascular system—hypothyroidism	0.00656	0.0255	CbGeAlD
Mefloquine—HBA1—adrenal gland—hypothyroidism	0.00565	0.022	CbGeAlD
Mefloquine—HBA1—blood—hypothyroidism	0.00565	0.022	CbGeAlD
Mefloquine—HBA1—female gonad—hypothyroidism	0.00527	0.0205	CbGeAlD
Mefloquine—HBA2—adrenal gland—hypothyroidism	0.00519	0.0202	CbGeAlD
Mefloquine—HBA2—blood—hypothyroidism	0.00519	0.0202	CbGeAlD
Mefloquine—Coma—Levothyroxine—hypothyroidism	0.00512	0.0181	CcSEcCtD
Mefloquine—Coma—Dextrothyroxine—hypothyroidism	0.00512	0.0181	CcSEcCtD
Mefloquine—HBA2—thyroid gland—hypothyroidism	0.00501	0.0195	CbGeAlD
Mefloquine—HBA2—female gonad—hypothyroidism	0.00484	0.0188	CbGeAlD
Mefloquine—HBA1—testis—hypothyroidism	0.00468	0.0182	CbGeAlD
Mefloquine—HBA1—liver—hypothyroidism	0.00442	0.0172	CbGeAlD
Mefloquine—HBA1—cerebellum—hypothyroidism	0.00432	0.0168	CbGeAlD
Mefloquine—Hypertension—Liothyronine—hypothyroidism	0.0043	0.0152	CcSEcCtD
Mefloquine—HBA2—testis—hypothyroidism	0.00429	0.0167	CbGeAlD
Mefloquine—HBA2—liver—hypothyroidism	0.00406	0.0158	CbGeAlD
Mefloquine—CYP3A4—urine—hypothyroidism	0.00401	0.0156	CbGeAlD
Mefloquine—Affect lability—Dextrothyroxine—hypothyroidism	0.004	0.0141	CcSEcCtD
Mefloquine—Affect lability—Levothyroxine—hypothyroidism	0.004	0.0141	CcSEcCtD
Mefloquine—Tachycardia—Liothyronine—hypothyroidism	0.00397	0.014	CcSEcCtD
Mefloquine—HBA2—cerebellum—hypothyroidism	0.00396	0.0154	CbGeAlD
Mefloquine—CYP2D6—urine—hypothyroidism	0.00395	0.0153	CbGeAlD
Mefloquine—Irritability—Dextrothyroxine—hypothyroidism	0.00388	0.0137	CcSEcCtD
Mefloquine—Irritability—Levothyroxine—hypothyroidism	0.00388	0.0137	CcSEcCtD
Mefloquine—Mood swings—Dextrothyroxine—hypothyroidism	0.00385	0.0136	CcSEcCtD
Mefloquine—Mood swings—Levothyroxine—hypothyroidism	0.00385	0.0136	CcSEcCtD
Mefloquine—Hypotension—Liothyronine—hypothyroidism	0.0038	0.0134	CcSEcCtD
Mefloquine—Coma—Liotrix—hypothyroidism	0.00376	0.0133	CcSEcCtD
Mefloquine—Muscular weakness—Levothyroxine—hypothyroidism	0.00358	0.0127	CcSEcCtD
Mefloquine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00358	0.0127	CcSEcCtD
Mefloquine—ADORA2A—cardiovascular system—hypothyroidism	0.00342	0.0133	CbGeAlD
Mefloquine—Body temperature increased—Liothyronine—hypothyroidism	0.00322	0.0114	CcSEcCtD
Mefloquine—ADORA1—heart—hypothyroidism	0.00313	0.0121	CbGeAlD
Mefloquine—ACHE—heart—hypothyroidism	0.00311	0.0121	CbGeAlD
Mefloquine—ADORA2A—gonad—hypothyroidism	0.0031	0.012	CbGeAlD
Mefloquine—Sweating—Dextrothyroxine—hypothyroidism	0.003	0.0106	CcSEcCtD
Mefloquine—Sweating—Levothyroxine—hypothyroidism	0.003	0.0106	CcSEcCtD
Mefloquine—ADORA1—cardiovascular system—hypothyroidism	0.00295	0.0115	CbGeAlD
Mefloquine—Affect lability—Liotrix—hypothyroidism	0.00294	0.0104	CcSEcCtD
Mefloquine—Irritability—Liotrix—hypothyroidism	0.00285	0.0101	CcSEcCtD
Mefloquine—Mood swings—Liotrix—hypothyroidism	0.00283	0.01	CcSEcCtD
Mefloquine—ADORA2A—adrenal gland—hypothyroidism	0.0027	0.0105	CbGeAlD
Mefloquine—ADORA2A—blood—hypothyroidism	0.0027	0.0105	CbGeAlD
Mefloquine—Muscular weakness—Liotrix—hypothyroidism	0.00264	0.00932	CcSEcCtD
Mefloquine—Flushing—Levothyroxine—hypothyroidism	0.00261	0.00922	CcSEcCtD
Mefloquine—Flushing—Dextrothyroxine—hypothyroidism	0.00261	0.00922	CcSEcCtD
Mefloquine—Alopecia—Levothyroxine—hypothyroidism	0.00248	0.00878	CcSEcCtD
Mefloquine—Alopecia—Dextrothyroxine—hypothyroidism	0.00248	0.00878	CcSEcCtD
Mefloquine—ADORA2A—Monoamine Transport—SLC5A7—hypothyroidism	0.00242	0.0825	CbGpPWpGaD
Mefloquine—ACHE—adrenal gland—hypothyroidism	0.00232	0.00901	CbGeAlD
Mefloquine—Tremor—Dextrothyroxine—hypothyroidism	0.00229	0.0081	CcSEcCtD
Mefloquine—Tremor—Levothyroxine—hypothyroidism	0.00229	0.0081	CcSEcCtD
Mefloquine—Renal failure—Liotrix—hypothyroidism	0.00226	0.008	CcSEcCtD
Mefloquine—ADORA1—thyroid gland—hypothyroidism	0.00225	0.00875	CbGeAlD
Mefloquine—Agitation—Levothyroxine—hypothyroidism	0.00225	0.00795	CcSEcCtD
Mefloquine—Agitation—Dextrothyroxine—hypothyroidism	0.00225	0.00795	CcSEcCtD
Mefloquine—ACHE—thyroid gland—hypothyroidism	0.00224	0.00869	CbGeAlD
Mefloquine—ADORA2A—testis—hypothyroidism	0.00223	0.00868	CbGeAlD
Mefloquine—Sweating—Liotrix—hypothyroidism	0.00221	0.0078	CcSEcCtD
Mefloquine—Palpitations—Dextrothyroxine—hypothyroidism	0.00216	0.00764	CcSEcCtD
Mefloquine—Palpitations—Levothyroxine—hypothyroidism	0.00216	0.00764	CcSEcCtD
Mefloquine—Convulsion—Levothyroxine—hypothyroidism	0.00212	0.00749	CcSEcCtD
Mefloquine—Convulsion—Dextrothyroxine—hypothyroidism	0.00212	0.00749	CcSEcCtD
Mefloquine—ADORA2A—liver—hypothyroidism	0.00211	0.00821	CbGeAlD
Mefloquine—Arthralgia—Levothyroxine—hypothyroidism	0.00208	0.00736	CcSEcCtD
Mefloquine—Arthralgia—Dextrothyroxine—hypothyroidism	0.00208	0.00736	CcSEcCtD
Mefloquine—Anxiety—Dextrothyroxine—hypothyroidism	0.00208	0.00734	CcSEcCtD
Mefloquine—Anxiety—Levothyroxine—hypothyroidism	0.00208	0.00734	CcSEcCtD
Mefloquine—ADORA2A—cerebellum—hypothyroidism	0.00206	0.00802	CbGeAlD
Mefloquine—Confusional state—Levothyroxine—hypothyroidism	0.00201	0.00712	CcSEcCtD
Mefloquine—Confusional state—Dextrothyroxine—hypothyroidism	0.00201	0.00712	CcSEcCtD
Mefloquine—Shock—Dextrothyroxine—hypothyroidism	0.00197	0.00694	CcSEcCtD
Mefloquine—Shock—Levothyroxine—hypothyroidism	0.00197	0.00694	CcSEcCtD
Mefloquine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00195	0.00689	CcSEcCtD
Mefloquine—Tachycardia—Levothyroxine—hypothyroidism	0.00195	0.00689	CcSEcCtD
Mefloquine—ACHE—Monoamine Transport—SLC5A7—hypothyroidism	0.00193	0.0659	CbGpPWpGaD
Mefloquine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00193	0.00682	CcSEcCtD
Mefloquine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00193	0.00682	CcSEcCtD
Mefloquine—ADORA1—testis—hypothyroidism	0.00193	0.0075	CbGeAlD
Mefloquine—Flushing—Liotrix—hypothyroidism	0.00192	0.00678	CcSEcCtD
Mefloquine—ACHE—testis—hypothyroidism	0.00192	0.00745	CbGeAlD
Mefloquine—Alopecia—Liotrix—hypothyroidism	0.00183	0.00646	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00182	0.00643	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00182	0.00643	CcSEcCtD
Mefloquine—CYP19A1—gonad—hypothyroidism	0.00182	0.00705	CbGeAlD
Mefloquine—Insomnia—Levothyroxine—hypothyroidism	0.00181	0.00638	CcSEcCtD
Mefloquine—Insomnia—Dextrothyroxine—hypothyroidism	0.00181	0.00638	CcSEcCtD
Mefloquine—ADORA1—cerebellum—hypothyroidism	0.00178	0.00692	CbGeAlD
Mefloquine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00178	0.00629	CcSEcCtD
Mefloquine—Dyspnoea—Levothyroxine—hypothyroidism	0.00178	0.00629	CcSEcCtD
Mefloquine—ACHE—cerebellum—hypothyroidism	0.00177	0.00688	CbGeAlD
Mefloquine—Fatigue—Dextrothyroxine—hypothyroidism	0.00172	0.00609	CcSEcCtD
Mefloquine—Fatigue—Levothyroxine—hypothyroidism	0.00172	0.00609	CcSEcCtD
Mefloquine—Vision blurred—Liotrix—hypothyroidism	0.0017	0.006	CcSEcCtD
Mefloquine—Tremor—Liotrix—hypothyroidism	0.00169	0.00596	CcSEcCtD
Mefloquine—Agitation—Liotrix—hypothyroidism	0.00165	0.00585	CcSEcCtD
Mefloquine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00165	0.00582	CcSEcCtD
Mefloquine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00165	0.00582	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00163	0.00577	CcSEcCtD
Mefloquine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00163	0.00577	CcSEcCtD
Mefloquine—Syncope—Liotrix—hypothyroidism	0.00161	0.00571	CcSEcCtD
Mefloquine—Palpitations—Liotrix—hypothyroidism	0.00159	0.00562	CcSEcCtD
Mefloquine—Urticaria—Levothyroxine—hypothyroidism	0.00159	0.00561	CcSEcCtD
Mefloquine—Urticaria—Dextrothyroxine—hypothyroidism	0.00159	0.00561	CcSEcCtD
Mefloquine—Loss of consciousness—Liotrix—hypothyroidism	0.00158	0.00559	CcSEcCtD
Mefloquine—CYP19A1—adrenal gland—hypothyroidism	0.00158	0.00615	CbGeAlD
Mefloquine—CYP19A1—blood—hypothyroidism	0.00158	0.00615	CbGeAlD
Mefloquine—Body temperature increased—Levothyroxine—hypothyroidism	0.00158	0.00558	CcSEcCtD
Mefloquine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00158	0.00558	CcSEcCtD
Mefloquine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00158	0.00558	CcSEcCtD
Mefloquine—Abdominal pain—Levothyroxine—hypothyroidism	0.00158	0.00558	CcSEcCtD
Mefloquine—Convulsion—Liotrix—hypothyroidism	0.00156	0.00551	CcSEcCtD
Mefloquine—Hypertension—Liotrix—hypothyroidism	0.00155	0.00549	CcSEcCtD
Mefloquine—Arthralgia—Liotrix—hypothyroidism	0.00153	0.00542	CcSEcCtD
Mefloquine—Chest pain—Liotrix—hypothyroidism	0.00153	0.00542	CcSEcCtD
Mefloquine—Anxiety—Liotrix—hypothyroidism	0.00153	0.0054	CcSEcCtD
Mefloquine—BCHE—heart—hypothyroidism	0.00153	0.00593	CbGeAlD
Mefloquine—CYP19A1—thyroid gland—hypothyroidism	0.00153	0.00593	CbGeAlD
Mefloquine—Confusional state—Liotrix—hypothyroidism	0.00148	0.00524	CcSEcCtD
Mefloquine—CYP19A1—female gonad—hypothyroidism	0.00148	0.00573	CbGeAlD
Mefloquine—Oedema—Liotrix—hypothyroidism	0.00147	0.00519	CcSEcCtD
Mefloquine—Anaphylactic shock—Liotrix—hypothyroidism	0.00147	0.00519	CcSEcCtD
Mefloquine—Shock—Liotrix—hypothyroidism	0.00145	0.00511	CcSEcCtD
Mefloquine—BCHE—cardiovascular system—hypothyroidism	0.00144	0.0056	CbGeAlD
Mefloquine—Tachycardia—Liotrix—hypothyroidism	0.00143	0.00507	CcSEcCtD
Mefloquine—Asthenia—Dextrothyroxine—hypothyroidism	0.00143	0.00506	CcSEcCtD
Mefloquine—Asthenia—Levothyroxine—hypothyroidism	0.00143	0.00506	CcSEcCtD
Mefloquine—Hyperhidrosis—Liotrix—hypothyroidism	0.00142	0.00502	CcSEcCtD
Mefloquine—Pruritus—Levothyroxine—hypothyroidism	0.00141	0.00499	CcSEcCtD
Mefloquine—Pruritus—Dextrothyroxine—hypothyroidism	0.00141	0.00499	CcSEcCtD
Mefloquine—Hypotension—Liotrix—hypothyroidism	0.00137	0.00485	CcSEcCtD
Mefloquine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00137	0.00483	CcSEcCtD
Mefloquine—Diarrhoea—Levothyroxine—hypothyroidism	0.00137	0.00483	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00134	0.00473	CcSEcCtD
Mefloquine—Insomnia—Liotrix—hypothyroidism	0.00133	0.0047	CcSEcCtD
Mefloquine—Paraesthesia—Liotrix—hypothyroidism	0.00132	0.00466	CcSEcCtD
Mefloquine—Dyspnoea—Liotrix—hypothyroidism	0.00131	0.00463	CcSEcCtD
Mefloquine—CYP19A1—testis—hypothyroidism	0.00131	0.00508	CbGeAlD
Mefloquine—Decreased appetite—Liotrix—hypothyroidism	0.00128	0.00451	CcSEcCtD
Mefloquine—BCHE—pituitary gland—hypothyroidism	0.00128	0.00496	CbGeAlD
Mefloquine—Vomiting—Levothyroxine—hypothyroidism	0.00127	0.00449	CcSEcCtD
Mefloquine—Vomiting—Dextrothyroxine—hypothyroidism	0.00127	0.00449	CcSEcCtD
Mefloquine—Fatigue—Liotrix—hypothyroidism	0.00127	0.00448	CcSEcCtD
Mefloquine—Rash—Dextrothyroxine—hypothyroidism	0.00126	0.00445	CcSEcCtD
Mefloquine—Rash—Levothyroxine—hypothyroidism	0.00126	0.00445	CcSEcCtD
Mefloquine—Dermatitis—Levothyroxine—hypothyroidism	0.00126	0.00445	CcSEcCtD
Mefloquine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00126	0.00445	CcSEcCtD
Mefloquine—Headache—Levothyroxine—hypothyroidism	0.00125	0.00442	CcSEcCtD
Mefloquine—Headache—Dextrothyroxine—hypothyroidism	0.00125	0.00442	CcSEcCtD
Mefloquine—CYP19A1—liver—hypothyroidism	0.00124	0.00481	CbGeAlD
Mefloquine—Feeling abnormal—Liotrix—hypothyroidism	0.00121	0.00428	CcSEcCtD
Mefloquine—Gastrointestinal pain—Liotrix—hypothyroidism	0.0012	0.00425	CcSEcCtD
Mefloquine—Nausea—Dextrothyroxine—hypothyroidism	0.00119	0.00419	CcSEcCtD
Mefloquine—Nausea—Levothyroxine—hypothyroidism	0.00119	0.00419	CcSEcCtD
Mefloquine—Urticaria—Liotrix—hypothyroidism	0.00117	0.00412	CcSEcCtD
Mefloquine—Abdominal pain—Liotrix—hypothyroidism	0.00116	0.0041	CcSEcCtD
Mefloquine—Body temperature increased—Liotrix—hypothyroidism	0.00116	0.0041	CcSEcCtD
Mefloquine—BCHE—adrenal gland—hypothyroidism	0.00114	0.00443	CbGeAlD
Mefloquine—BCHE—blood—hypothyroidism	0.00114	0.00443	CbGeAlD
Mefloquine—BCHE—thyroid gland—hypothyroidism	0.0011	0.00427	CbGeAlD
Mefloquine—Hypersensitivity—Liotrix—hypothyroidism	0.00108	0.00383	CcSEcCtD
Mefloquine—Asthenia—Liotrix—hypothyroidism	0.00105	0.00373	CcSEcCtD
Mefloquine—Pruritus—Liotrix—hypothyroidism	0.00104	0.00367	CcSEcCtD
Mefloquine—Diarrhoea—Liotrix—hypothyroidism	0.00101	0.00355	CcSEcCtD
Mefloquine—Dizziness—Liotrix—hypothyroidism	0.000972	0.00343	CcSEcCtD
Mefloquine—BCHE—testis—hypothyroidism	0.000942	0.00366	CbGeAlD
Mefloquine—Vomiting—Liotrix—hypothyroidism	0.000934	0.0033	CcSEcCtD
Mefloquine—Rash—Liotrix—hypothyroidism	0.000927	0.00327	CcSEcCtD
Mefloquine—Dermatitis—Liotrix—hypothyroidism	0.000926	0.00327	CcSEcCtD
Mefloquine—Headache—Liotrix—hypothyroidism	0.000921	0.00325	CcSEcCtD
Mefloquine—BCHE—liver—hypothyroidism	0.000891	0.00346	CbGeAlD
Mefloquine—Nausea—Liotrix—hypothyroidism	0.000873	0.00308	CcSEcCtD
Mefloquine—BCHE—cerebellum—hypothyroidism	0.00087	0.00338	CbGeAlD
Mefloquine—HBA2—Metabolism—IYD—hypothyroidism	0.000816	0.0278	CbGpPWpGaD
Mefloquine—CYP3A4—blood—hypothyroidism	0.000767	0.00298	CbGeAlD
Mefloquine—CYP2D6—blood—hypothyroidism	0.000755	0.00293	CbGeAlD
Mefloquine—ABCB1—adrenal cortex—hypothyroidism	0.000752	0.00292	CbGeAlD
Mefloquine—ABCB1—heart—hypothyroidism	0.000728	0.00283	CbGeAlD
Mefloquine—CYP2D6—female gonad—hypothyroidism	0.000704	0.00274	CbGeAlD
Mefloquine—HBA2—Metabolism—ATP5O—hypothyroidism	0.000693	0.0236	CbGpPWpGaD
Mefloquine—ABCB1—cardiovascular system—hypothyroidism	0.000687	0.00267	CbGeAlD
Mefloquine—HBA2—Metabolism—TPO—hypothyroidism	0.000652	0.0222	CbGpPWpGaD
Mefloquine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.000645	0.022	CbGpPWpGaD
Mefloquine—CYP2D6—testis—hypothyroidism	0.000624	0.00243	CbGeAlD
Mefloquine—ABCB1—gonad—hypothyroidism	0.000623	0.00242	CbGeAlD
Mefloquine—HBA1—Metabolism—IYD—hypothyroidism	0.000618	0.0211	CbGpPWpGaD
Mefloquine—ABCB1—pituitary gland—hypothyroidism	0.000608	0.00236	CbGeAlD
Mefloquine—CYP3A4—liver—hypothyroidism	0.0006	0.00233	CbGeAlD
Mefloquine—ADORA1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000597	0.0203	CbGpPWpGaD
Mefloquine—CYP2D6—liver—hypothyroidism	0.00059	0.00229	CbGeAlD
Mefloquine—CYP2D6—cerebellum—hypothyroidism	0.000577	0.00224	CbGeAlD
Mefloquine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.000575	0.0196	CbGpPWpGaD
Mefloquine—ABCB1—adrenal gland—hypothyroidism	0.000543	0.00211	CbGeAlD
Mefloquine—ABCB1—blood—hypothyroidism	0.000543	0.00211	CbGeAlD
Mefloquine—HBA1—Metabolism—ATP5O—hypothyroidism	0.000526	0.0179	CbGpPWpGaD
Mefloquine—ABCB1—thyroid gland—hypothyroidism	0.000524	0.00204	CbGeAlD
Mefloquine—ABCB1—female gonad—hypothyroidism	0.000506	0.00197	CbGeAlD
Mefloquine—HBA1—Metabolism—TPO—hypothyroidism	0.000494	0.0168	CbGpPWpGaD
Mefloquine—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.000484	0.0165	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.000472	0.0161	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000461	0.0157	CbGpPWpGaD
Mefloquine—ABCB1—testis—hypothyroidism	0.000449	0.00175	CbGeAlD
Mefloquine—ACHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000446	0.0152	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—TSHR—hypothyroidism	0.000437	0.0149	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—TSHB—hypothyroidism	0.000437	0.0149	CbGpPWpGaD
Mefloquine—ABCB1—liver—hypothyroidism	0.000425	0.00165	CbGeAlD
Mefloquine—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.000421	0.0144	CbGpPWpGaD
Mefloquine—ABCB1—cerebellum—hypothyroidism	0.000415	0.00161	CbGeAlD
Mefloquine—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000398	0.0136	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.000362	0.0124	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SLC5A7—hypothyroidism	0.000342	0.0116	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC5A7—hypothyroidism	0.000305	0.0104	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000303	0.0103	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—TSHB—hypothyroidism	0.000302	0.0103	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000288	0.0098	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000286	0.00974	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00027	0.0092	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00027	0.0092	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PIK3C2A—hypothyroidism	0.000269	0.00917	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—AVP—hypothyroidism	0.000258	0.00878	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000256	0.00874	CbGpPWpGaD
Mefloquine—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000255	0.00869	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000234	0.00797	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—TRH—hypothyroidism	0.000231	0.00786	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—TSHB—hypothyroidism	0.000229	0.0078	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—AVP—hypothyroidism	0.000227	0.00773	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—SLC5A5—hypothyroidism	0.000226	0.0077	CbGpPWpGaD
Mefloquine—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000225	0.00766	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—NEFL—hypothyroidism	0.00022	0.00751	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000208	0.0071	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000208	0.0071	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—TSHR—hypothyroidism	0.000206	0.00701	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—TSHB—hypothyroidism	0.000206	0.00701	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PIK3C2A—hypothyroidism	0.000204	0.00695	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—NEFL—hypothyroidism	0.000197	0.0067	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000185	0.0063	CbGpPWpGaD
Mefloquine—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000182	0.00621	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—TRH—hypothyroidism	0.000178	0.00607	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000178	0.00606	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—AVP—hypothyroidism	0.000175	0.00597	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—SLC5A5—hypothyroidism	0.000171	0.00584	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—POMC—hypothyroidism	0.000171	0.00584	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000165	0.00562	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000159	0.00542	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000159	0.00541	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—TSHB—hypothyroidism	0.000159	0.00541	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—TSHR—hypothyroidism	0.000159	0.00541	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—VAV3—hypothyroidism	0.000137	0.00467	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—POMC—hypothyroidism	0.000133	0.00453	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TRH—hypothyroidism	0.00013	0.00444	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—IYD—hypothyroidism	0.000124	0.00423	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000123	0.00419	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—AVP—hypothyroidism	0.000121	0.00413	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TRH—hypothyroidism	0.000118	0.00403	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—POMC—hypothyroidism	0.000118	0.00403	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TSHB—hypothyroidism	0.000116	0.00396	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TSHR—hypothyroidism	0.000116	0.00396	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—IYD—hypothyroidism	0.000114	0.00389	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—IYD—hypothyroidism	0.000111	0.00378	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000106	0.0036	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ATP5O—hypothyroidism	0.000106	0.0036	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TSHB—hypothyroidism	0.000106	0.0036	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TSHR—hypothyroidism	0.000106	0.0036	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TRH—hypothyroidism	0.000101	0.00343	CbGpPWpGaD
Mefloquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.0001	0.00342	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TPO—hypothyroidism	9.93e-05	0.00338	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ATP5O—hypothyroidism	9.7e-05	0.00331	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—POMC—hypothyroidism	9.67e-05	0.0033	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ATP5O—hypothyroidism	9.42e-05	0.00321	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—AVP—hypothyroidism	9.36e-05	0.00319	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	9.31e-05	0.00317	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.2e-05	0.00314	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TRH—hypothyroidism	9.14e-05	0.00311	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TPO—hypothyroidism	9.12e-05	0.00311	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TSHB—hypothyroidism	8.97e-05	0.00306	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TSHR—hypothyroidism	8.97e-05	0.00306	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—POMC—hypothyroidism	8.96e-05	0.00305	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—TSHB—hypothyroidism	8.92e-05	0.00304	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TPO—hypothyroidism	8.86e-05	0.00302	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.45e-05	0.00288	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.21e-05	0.0028	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.16e-05	0.00278	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TSHB—hypothyroidism	8.15e-05	0.00278	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TSHR—hypothyroidism	8.15e-05	0.00278	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.13e-05	0.00277	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CLTC—hypothyroidism	8.09e-05	0.00276	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—POMC—hypothyroidism	8.05e-05	0.00274	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8e-05	0.00273	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—TSHB—hypothyroidism	7.96e-05	0.00271	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—VAV3—hypothyroidism	7.11e-05	0.00242	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TRH—hypothyroidism	6.99e-05	0.00238	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AVP—hypothyroidism	6.85e-05	0.00233	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.63e-05	0.00226	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.56e-05	0.00223	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—VAV3—hypothyroidism	6.45e-05	0.0022	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CLTC—hypothyroidism	6.25e-05	0.00213	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TSHB—hypothyroidism	6.23e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TSHR—hypothyroidism	6.23e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AVP—hypothyroidism	6.22e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—POMC—hypothyroidism	6.22e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SH2B3—hypothyroidism	5.56e-05	0.00189	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—VAV3—hypothyroidism	5.49e-05	0.00187	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—IYD—hypothyroidism	5.41e-05	0.00184	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TRH—hypothyroidism	5.4e-05	0.00184	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.31e-05	0.00181	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AVP—hypothyroidism	5.29e-05	0.0018	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—IYD—hypothyroidism	5.09e-05	0.00174	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—VAV3—hypothyroidism	4.98e-05	0.0017	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TSHB—hypothyroidism	4.81e-05	0.00164	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TSHR—hypothyroidism	4.81e-05	0.00164	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AVP—hypothyroidism	4.8e-05	0.00164	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ATP5O—hypothyroidism	4.6e-05	0.00157	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TSHB—hypothyroidism	4.6e-05	0.00157	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—POMC—hypothyroidism	4.55e-05	0.00155	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ATP5O—hypothyroidism	4.33e-05	0.00148	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TPO—hypothyroidism	4.32e-05	0.00147	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—POMC—hypothyroidism	4.32e-05	0.00147	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SH2B3—hypothyroidism	4.29e-05	0.00146	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TSHB—hypothyroidism	4.22e-05	0.00144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—POMC—hypothyroidism	4.13e-05	0.00141	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PRL—hypothyroidism	4.12e-05	0.0014	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TSHB—hypothyroidism	4.1e-05	0.0014	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3C2A—hypothyroidism	4.1e-05	0.0014	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TPO—hypothyroidism	4.07e-05	0.00139	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	4.05e-05	0.00138	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.04e-05	0.00138	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VAV3—hypothyroidism	3.81e-05	0.0013	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	3.76e-05	0.00128	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.71e-05	0.00127	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AVP—hypothyroidism	3.67e-05	0.00125	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3C2A—hypothyroidism	3.65e-05	0.00125	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.61e-05	0.00123	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—POMC—hypothyroidism	3.51e-05	0.0012	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—POMC—hypothyroidism	3.49e-05	0.00119	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC5A5—hypothyroidism	3.44e-05	0.00117	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—IGF1—hypothyroidism	3.36e-05	0.00114	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—IYD—hypothyroidism	3.33e-05	0.00114	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.2e-05	0.00109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—POMC—hypothyroidism	3.19e-05	0.00109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRL—hypothyroidism	3.18e-05	0.00108	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC5A5—hypothyroidism	3.16e-05	0.00108	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—POMC—hypothyroidism	3.12e-05	0.00106	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC5A5—hypothyroidism	3.07e-05	0.00105	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—IGF1—hypothyroidism	3e-05	0.00102	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VAV3—hypothyroidism	2.94e-05	0.001	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AVP—hypothyroidism	2.84e-05	0.000967	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.83e-05	0.000965	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.82e-05	0.000962	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TPO—hypothyroidism	2.66e-05	0.000907	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.52e-05	0.000858	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—POMC—hypothyroidism	2.44e-05	0.000832	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1—hypothyroidism	2.35e-05	0.0008	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TSHB—hypothyroidism	2e-05	0.000682	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TSHB—hypothyroidism	1.89e-05	0.000643	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—POMC—hypothyroidism	1.88e-05	0.000642	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	0.000618	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—POMC—hypothyroidism	1.8e-05	0.000614	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.78e-05	0.000608	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.68e-05	0.000573	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—POMC—hypothyroidism	1.65e-05	0.000564	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—POMC—hypothyroidism	1.61e-05	0.000547	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.5e-05	0.00051	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.41e-05	0.000481	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TSHB—hypothyroidism	1.23e-05	0.00042	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.1e-05	0.000374	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	9.23e-06	0.000314	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—POMC—hypothyroidism	7.84e-06	0.000267	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—POMC—hypothyroidism	7.38e-06	0.000252	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—POMC—hypothyroidism	4.83e-06	0.000165	CbGpPWpGaD
